ORO Labs has raised $100 million in Series C led by Brighton Park Capital and Goldman Sachs Alternatives Growth Equity, with participation from Norwest Venture Partners, B Capital, XYZ Capital, and Felicis, to advance AI-driven procurement orchestration for enterprises.

The platform aims to simplify procurement with seamless user experiences, faster cycle times, end-to-end visibility, and intelligent workflows that adapt to market changes through deep system integrations.

CEO Sudhir Bhojwani says procurement is moving to an AI-driven operating model, and ORO delivers modernization and ROI via intelligent automation while preserving controls and standards.

Key capabilities include demand intake, approvals, sourcing coordination, supplier onboarding, and risk management, all integrated with ERP, contracts, and supplier databases.

ORO’s AI-native platform supports supplier onboarding, source-to-pay, spend analytics, category intelligence, sourcing optimization, contract management, and risk assessment via a dynamic knowledge graph for continuous learning.

The system is designed to reduce lead times and non-compliant spending, delivering end-to-end visibility and seamless integration with existing tech stacks without disrupting legacy infrastructure.

The company reported 300% revenue growth over the past year and expects to triple revenue again this year, with a 150% revenue retention rate signaling strong expansion within existing customers.

The platform acts as an orchestration layer across supplier onboarding, source-to-pay, spend and category intelligence, negotiations, supplier intelligence, contracts, and risk management, designed to augment rather than replace legacy software.

The investment will accelerate go-to-market expansion and product development to help customers navigate procurement challenges amid market volatility.

Funding will accelerate product innovation, extend the technology to more organizations, and enhance the platform’s operational value and resilience through a knowledge-graph approach tailored to each company.

Early case studies show faster compliance checks for a major global pharmaceutical client, illustrating efficiency gains and accuracy improvements across complex supply chains.

Major customers include Coca-Cola, Siemens Energy, Novartis, Booking.com, Roche, and Gilead Sciences, with deployments in 100+ countries across diverse industries, underscoring broad enterprise reach.